INMB shows renewed optimism: analyst consensus remains bullish, with 12-month targets averaging between $7.75–$8.57—up to ~300% upside. Standouts include a high of $21 (TipRanks) and average of $9.53 (StockAnalysis). #INMB#Biotech#StockAnalysis#Stocks#Stockmarket
BTC is advancing in Wave 3 of a bullish Elliott pattern, with Fibonacci pointing toward the $123K zone next—invalidated only if we drop below $107K. Momentum favors the upside. #BTC#Bitcoin#ElliottWave#CryptoAnalysis#PriceTarget